168 related articles for article (PubMed ID: 15388640)
1. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products.
Yeh M; Cole AL; Choi J; Liu Y; Tulchinsky D; Qiao JH; Fishbein MC; Dooley AN; Hovnanian T; Mouilleseaux K; Vora DK; Yang WP; Gargalovic P; Kirchgessner T; Shyy JY; Berliner JA
Circ Res; 2004 Oct; 95(8):780-8. PubMed ID: 15388640
[TBL] [Abstract][Full Text] [Related]
2. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins.
Yabe D; Brown MS; Goldstein JL
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12753-8. PubMed ID: 12242332
[TBL] [Abstract][Full Text] [Related]
3. The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP.
Janowski BA
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12675-80. PubMed ID: 12242342
[TBL] [Abstract][Full Text] [Related]
4. Transcription-dependent degradation controls the stability of the SREBP family of transcription factors.
Sundqvist A; Ericsson J
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13833-8. PubMed ID: 14615581
[TBL] [Abstract][Full Text] [Related]
5. Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex.
Cubells L; Vilà de Muga S; Tebar F; Wood P; Evans R; Ingelmo-Torres M; Calvo M; Gaus K; Pol A; Grewal T; Enrich C
Traffic; 2007 Nov; 8(11):1568-89. PubMed ID: 17822395
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
7. SREBP2 regulates the endothelial response to cytokines via direct transcriptional activation of KLF6.
Fowler JWM; Boutagy NE; Zhang R; Horikami D; Whalen MB; Romanoski CE; Sessa WC
J Lipid Res; 2023 Aug; 64(8):100411. PubMed ID: 37437844
[TBL] [Abstract][Full Text] [Related]
8. SPRING is a Dedicated Licensing Factor for SREBP-Specific Activation by S1P.
Hendrix S; Tan JME; Ndoj K; Kingma J; Valiloo M; Zijlstra LF; Ottenhoff R; Seidah NG; Loregger A; Kober DL; Zelcer N
Mol Cell Biol; 2024; 44(4):123-137. PubMed ID: 38747374
[TBL] [Abstract][Full Text] [Related]
9. Novel cholesterol-dependent regulation of cardiac K
Geiger R; Fatima N; Schooley JF; Smyth JT; Haigney MC; Flagg TP
Physiol Rep; 2021 Jan; 8(24):e14675. PubMed ID: 33356020
[TBL] [Abstract][Full Text] [Related]
10. Metabolic coessentiality mapping identifies C12orf49 as a regulator of SREBP processing and cholesterol metabolism.
Bayraktar EC; La K; Karpman K; Unlu G; Ozerdem C; Ritter DJ; Alwaseem H; Molina H; Hoffmann HH; Millner A; Atilla-Gokcumen GE; Gamazon ER; Rushing AR; Knapik EW; Basu S; Birsoy K
Nat Metab; 2020 Jun; 2(6):487-498. PubMed ID: 32694732
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol depletion increases membrane stiffness of aortic endothelial cells.
Byfield FJ; Aranda-Espinoza H; Romanenko VG; Rothblat GH; Levitan I
Biophys J; 2004 Nov; 87(5):3336-43. PubMed ID: 15347591
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.
Gerin I; Clerbaux LA; Haumont O; Lanthier N; Das AK; Burant CF; Leclercq IA; MacDougald OA; Bommer GT
J Biol Chem; 2010 Oct; 285(44):33652-61. PubMed ID: 20732877
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.
Zidovetzki R; Levitan I
Biochim Biophys Acta; 2007 Jun; 1768(6):1311-24. PubMed ID: 17493580
[TBL] [Abstract][Full Text] [Related]
14. An adhesion-based method for plasma membrane isolation: evaluating cholesterol extraction from cells and their membranes.
Bezrukov L; Blank PS; Polozov IV; Zimmerberg J
Anal Biochem; 2009 Nov; 394(2):171-6. PubMed ID: 19631189
[TBL] [Abstract][Full Text] [Related]
15. Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets.
Silverio A; Cancro FP; Esposito L; Bellino M; D'Elia D; Verdoia M; Vassallo MG; Ciccarelli M; Vecchione C; Galasso G; De Luca G
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983163
[TBL] [Abstract][Full Text] [Related]
16. OxPAPC stabilizes liquid-ordered domains in biomimetic membranes.
Cavazos AT; Pennington ER; Dadoo S; Gowdy KM; Wassall SR; Shaikh SR
Biophys J; 2023 Mar; 122(6):1130-1139. PubMed ID: 36840353
[TBL] [Abstract][Full Text] [Related]
17. Low Concentrations of Oxidized Phospholipids Increase Stress Tolerance of Endothelial Cells.
Mauerhofer C; Afonyushkin T; Oskolkova OV; Hellauer K; Gesslbauer B; Schmerda J; Ke Y; Zimmer A; Birukova AA; Birukov KG; Bochkov V
Antioxidants (Basel); 2022 Sep; 11(9):. PubMed ID: 36139816
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory stress signaling via NF-
Fowler JWM; Zhang R; Tao B; Boutagy NE; Sessa WC
Elife; 2022 Aug; 11():. PubMed ID: 35959888
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin inhibits POVPC-mediated induction of endothelial-to-mesenchymal cell transition.
Li Y; Zhang YX; Ning DS; Chen J; Li SX; Mo ZW; Peng YM; He SH; Chen YT; Zheng CJ; Gao JJ; Yuan HX; Ou JS; Ou ZJ
J Lipid Res; 2021; 62():100066. PubMed ID: 33711324
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
